Liposomal Dendritic Cell Vaccine in Breast Cancer Immunotherapy
Authors:
Open Access
- 25 January 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 6 (5) , 3991-3998
Abstract
Cancer vaccine is well recognized as a promising approach for immunotherapy of cancers. Since dendritic cells (DCs) are capable of processing and presenting antigens to initiate the immune response cascade, the development of DC vaccines is considered as a good choice for the treatment of cancer. Herein, a folic acid (FA)-modified liposome was constructed and loaded with chlorin e6 (Ce6) as a DC vaccine (FA-Lipo-Ce6). It was suggested that the loaded Ce6 within FA-Lipo-Ce6 can be activated under laser irradiation. The photodynamic therapy (PDT) of Ce6 was expected to create on-demand reactive oxygen species (ROS) in situ, which causes cell death and trigger the exposure of tumor-associated antigen (TAA). In addition, the produced ROS can mimic the inflammatory responses for the employment of DC for better antigen presentation and immune response. Most importantly, the employment of DC can recognize the exposed TAA to stimulate DC for effective vaccination in situ. Our results demonstrated the powerful capacity of FA-Lipo-Ce6 to induce DC activation, leading to effective suppression of the growth of breast cancers.Keywords
This publication has 38 references indexed in Scilit:
- pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cellsCarbohydrate Polymers, 2018
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapyNature Communications, 2017
- A cancer cell specific targeting nanocomplex for combination of mRNA-responsive photodynamic and chemo-therapyChemical Communications, 2017
- Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancerRSC Advances, 2017
- iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting abilityInternational Journal of Nanomedicine, 2017
- Engineering Recombinant Virus-like Nanoparticles from Plants for Cellular DeliveryACS Nano, 2017
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapyNature Communications, 2016
- Adoptive immunotherapy for cancer: harnessing the T cell responseNature Reviews Immunology, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapyNature Nanotechnology, 2011